Survival rates and quality of life of patients after thoracic endovascular aortic repair

Abstract

Introduction. Aim. This study aimed to assess patients' quality of life of patients after thoracic endovascular aortic repair (TEVAR). Methods. The clinical data of 42 patients (mean age of 58.7±4.1 years, 32 men, 10 women) underwent TEVAR from 2016 to 2022 were analyzed. The mean follow-up period was 2.7±0.25 years. The thoracic aortic aneurysm was diagnosed in 11 out of 42 cases. TEVAR was performed in 31 of 42 patients with aortic dissection (24 cases had type B, 4 cases had type "neither A nor B", and 3 had type A). Hybrid surgeries were performed in 12 patients, including 3 significant surgeries with prosthetics of the ascending and aortic arch, 3 cases with parallel carotid-subclavian bypass, and 6 of patients with stenting of the common carotid artery and endoprosthesis replacement of the left subclavian artery. Results. The cumulative survival rate at 30 days was 97.6%, 6-month survival was 88.1%, and 3-year survival was 85.7%. The dynamics of assessments by SF-36 domains showed that after TEVAR, vital activity and mental health fields were the most effective. So, if before TEVAR in the binding activity domain, the average quality of life was 63.8±7.2, then after 12 months, the indicator increased with a statistically significant differenceto 86.2±6.4 (P<0.001). The patient's mental health improved significantly with SF-36 scores after TEVAR rate of 77.4±4.4. Also. All other domains enhanced considerably compared to the pre-TEVAR survey results (P<0.01). Conclusion. TEVAR showed high efficiency with significant improvement in the general condition and quality of life of patients.